BACKGROUND: Laparotomy followed by inpatient hospitalization has traditionally been the most common surgical care for hysterectomy. The financial implications of the increased use of laparoscopy and outpatient hysterectomy are unknown. OBJECTIVES: The objective of the study was to quantify the increasing use of laparoscopy and outpatient hysterectomy and to describe the financial implications among women with commercially based insurance in the United States. STUDY DESIGN: Hysterectomies between 2010 and 2013 were identified in the Health Care Cost Institute, a national data set with inpatient and outpatient private insurance claims for more than 25 million women. Surgical approach was categorized with procedure codes as abdominal, laparoscopic, laparoscopic assisted vaginal, or vaginal. Payments were adjusted to 2013 US dollars to account for change because of inflation. RESULTS: Between 2010 and 2013, there were 386,226 women who underwent hysterectomy. The rate of utilization decreased 12.4%, from 39.9 to 35.0 hysterectomies per 10,000 women. The largest absolute decreases were observed among women younger than 55 years and among those with uterine fibroids, abnormal uterine bleeding, and endometriosis. The proportion of laparoscopic hysterectomies increased from 26.1% to 43.4%, with concomitant decreases in abdominal (38.6% to 28.3%), laparoscopic assisted vaginal (20.2 to 16.7%), and vaginal (15.1% to 11.5%) hysterectomies. There was also a shift from inpatient to outpatient surgery. In 2010, the inpatient and outpatient rates of hysterectomy were 26.6 and 13.3 per 10,000 women, respectively. By 2013, the rates were 15.4 and 19.6 per 10,000 women. In each year of analysis, the average reimbursement for outpatient procedures was 44-46% less than for similar inpatient procedures. Offsetting the lower utilization of hysterectomy and lower reimbursement for outpatient surgery were increases in average inpatient and outpatient hysterectomy reimbursement of 19.4% and 19.8%, respectively. Total payments for hysterectomy decreased 6.3%, from $823.4 million to $771.3 million. CONCLUSION: Between 2010 and 2013, laparoscopy emerged as the most common surgical approach for hysterectomy, and outpatient hysterectomy became more common than inpatient among women with commercially based insurance. While average reimbursement per case increased, overall payments for hysterectomy are decreasing because of decreased utilization and dramatic differences in how hysterectomy is performed.
U tilization of hysterectomy, the second most common procedure performed among women in the United States, is rapidly evolving. 1 National claims data in one study revealed that the median number of inpatient hysterectomies per hospital decreased by 40% over 10 years. 2 However, it is possible that the dissemination of minimally invasive hysterectomy techniques, especially laparoscopy, has led to protocols promoting outpatient hysterectomy. [3] [4] [5] Because ambulatory data are often not included in large national claims data sets, it is unclear whether the declines in inpatient hysterectomy are due to an overall decrease in hysterectomy utilization or a shift toward outpatient care.
The financial impact of these changes in practice is unclear. The widespread adoption of laparoscopy, in particular robotic-assisted technology, could have profound financial repercussions. The American College of Obstetricians and Gynecologists (ACOG) estimated that robotic hysterectomy could add $900 million to $1.9 billion to annual health care spending. 6 The financial implications of these changes in practice have not been evaluated among commercially insured women.
The Health Care Cost Institute, a nonpartisan, nonprofit organization, contains inpatient and outpatient claims data from 3 large commercial insurers. It is well suited for an analysis of care received by US women in their fourth, fifth, and sixth decades, a time of life when most women are covered by private insurance and when hysterectomy is most commonly performed.
We sought to quantify the emergence of laparoscopy as the predominant surgical approach for hysterectomy, to describe the shift from inpatient to outpatient surgery, and to analyze the financial implications of these changes. This analysis seeks to provide transparency to patients, hospitals, and insurers regarding the diffusion of technology and its impact on utilization and payment for this common surgery.
Materials and Methods
We used data from the Health Care Cost Institute, a repository for inpatient and outpatient claims for more than 25 million women whose health insurance coverage was provided by Aetna, Hysterectomies performed between Jan. 1, 2010, and Dec. 31, 2013, were identified using procedure codes of the International Classification of Diseases, version 9 (ICD9), and Current Procedural Terminology, version 4, systems. The surgical approach for hysterectomy was determined primarily with ICD9 procedure codes; when ICD9 codes were not available, a Current Procedural Terminology, version 4, code was used instead. When cases had more than 1 surgical approach indicated by these codes, the surgical approach was categorized with the less invasive approach.
We chose to categorize cases in this manner to be consistent with an intentto-treat analysis. Clinically it is most common that a surgery would transition from a minimally invasive to an open approach in the event of unexpected pathology or complications. A case involving the surgical judgment that conversion is required will involve greater resource use (eg, additional instruments, more surgical time, and inpatient admission) and will result in higher payment, even in the absence of complications.
Using the intent-to-treat principle, this resource use is attributed to the less invasive, less morbid outpatient approach rather than the already comparatively more morbid, inpatient abdominal approach. Thus, if vaginal and abdominal procedure codes were present, the case was analyzed with the vaginal surgical approach group. If both laparoscopic and abdominal approaches were present, the case was analyzed with the laparoscopic surgical approach group. Procedures with a roboticassisted ICD9 procedure code (17.42, 17.44) were considered laparoscopic hysterectomies.
Surgical indications for hysterectomy were identified using ICD9 diagnostic codes. Three diagnostic codes were available to allow for the identification of hysterectomies for multiple indications. In alphabetical order, the indications were abnormal uterine bleeding (AUB); cancers of the cervix, uterus, ovary, unspecified female organ; cervical dysplasia; endometrial hyperplasia; endometriosis, noninflammatory disorders and pelvic pain; family or personal history of malignancy; leiomyomata; obstetrical complications; pelvic organ prolapse; pelvic inflammatory disease; and premalignant lesions or tumors of uncertain behavior. The ICD9 codes used in each of these groups are provided in Supplemental Table 1 .
Utilization, the number of women per 10,000 who underwent hysterectomy, was analyzed with adjustments for statelevel variation in the proportion of women in the Health Care Cost Institute and differences in age across states. A patient's residence was determined by their location at the beginning of the calendar year. The number of hysterectomies among women enrolled in the Health Care Cost Institute was tallied for each state in each calendar year.
To estimate the number of hysterectomies in any state, we took into account how many women had insurance with 1 of the 3 carriers in the Health Care Cost Institute and the number of women in that respective state with commercially based insurance according to the US Census. Thus, the state count of hysterectomies was divided by the ratio of the number of patients covered by 1 of the 3 insurance carriers over the number with commercially based insurance. Indirect age adjustment, as described by the Dartmouth Atlas of Healthcare, was used to account for the differing proportions of women in the age bands of 18e24, 25e34, 35e44, 45e54, 55e64, 65e74, and >75 years. 7 Age-adjusted rates for inpatient, outpatient, and overall utilization (both inpatient and outpatient cases) were then calculated at the state level.
We also analyzed changes between the bookend years of 2010 and 2013. The overall percentage difference in the rates of hysterectomy for each state between 2010 and 2013 was calculated and ranked from largest to smallest relative decrease. The state rates for 2010 and 2013 were combined, and the decile limits for inpatient, outpatient, and overall utilization were each identified. State utilization rates were mapped to show the relative changes across the states. Box plots showing the median and interquartile range were developed to illustrate the trends in state-level Payments were analyzed after adjustment to 2013 US dollars using the medical consumer price index. Facility payments and patient cost share payments (ie, out-of-pocket expenses) for the hysterectomy, provided by the Health Care Cost Institute, were used in the analysis. The facility payment is the amount reimbursed by the insurance company to the hospital, and the patient cost share is the sum of coinsurance, copayments, and deductibles made by the patient. Total payment is the sum of the facility payment and patient cost share.
Results
We identified 386,226 women who underwent hysterectomy during 102,747,857 woman-years of observation in the Health Care Cost Institute data. Uterine fibroids, abnormal uterine bleeding, and endometriosis were the 3 most common indications for surgery. A total of 78.3% of the hysterectomies (n ¼ 302,547) were performed on women <55 years of age. The utilization of hysterectomies decreased 12.3% overall. In the 4 calendar years, the rate declined from 39.9, to 39.0, to 36.5, to 35.0 hysterectomies per 10,000 women (Table) . The annualized average decrease in hysterectomy utilization was 4.3%.
Patient demographics and diagnoses between 2010 and 2013 were analyzed (Table) . Among women aged <35, 36e44, and 45e54 years, there were decreases in utilization of 22.2%, 16.9%, and 15.2%, respectively. In contrast, the utilization of hysterectomy among women aged 55e64 years decreased only 0.3%, and among women aged 65e74 and >74 years, the rate increased 17.1% and 1.3%, respectively.
The use of ICD9 codes for uterine fibroids, abnormal uterine bleeding, and endometriosis decreased 11.4%, 17.7%, and 9.4%, respectively. The use of pelvic organ prolapse and pelvic inflammatory disease, the fourth and fifth most common diagnoses, decreased 17% and 20%. The proportion of hysterectomies for uterine cancer increased 4%, while the proportion performed for ovarian cancer, cervical cancer, poorly specified cancers, premalignant conditions (cervical dysplasia, endometrial hyperplasia), and a family history of cancer was relatively stable.
Choice of surgical approach, payments made by insurance companies and patients, and facility reimbursement for hysterectomy changed substantially between 2010 and 2013 (Table) . The 
ajog.org

GYNECOLOGY Original Research
proportion of hysterectomies performed laparoscopically increased from 26.1% to 43.4%. In 2012, laparoscopy emerged as the most common surgical approach for hysterectomy. There were concomitant decreases in the proportion of nonlaparoscopic hysterectomies, which include abdominal, vaginal, and laparoscopic-assisted vaginal cases. There was a 34.1% decline in the proportion of hysterectomies performed inpatient and a small decrease in the average length of stay.
The payment for and utilization of hysterectomy in the inpatient and outpatient setting in each of the 4 years is illustrated in Figure 1 . Between 2010 and 2013, reimbursement for outpatient hysterectomy was 44e46% lower than that for the inpatient (eg, in 2010: [$5100e9451]/$9451 * 100%). The average increase in payment per hysterectomy was 19.4% (eg, [$11,284e9451]/ $9451 * 100%) for the inpatient and 19.8% (eg, [$6112e5,100)/$5100 * 100%) for the outpatient. In 2010, inpatient hysterectomy was twice as common as outpatient. With each year, the gap narrowed, and in 2013, outpatient hysterectomy became more common than the inpatient.
Trends in the average payment for inpatient and outpatient hysterectomy by each surgical approach are provided in Figure 2 . The per-case payments for hysterectomy, adjusted for inflation, increased for all surgical approaches and for both inpatient and outpatient cases between 2010 and 2013. In comparison with a vaginal approach, there is an additional expense associated with laparoscopy (both total laparoscopic and laparoscopic-assisted vaginal hysterectomy) for inpatient and outpatient hysterectomy.
Payments for abdominal hysterectomies, preformed predominantly inpatient, were similar to those for hysterectomy performed with laparoscopy. The proportion of outpatient abdominal hysterectomies is <1% of hysterectomies in all the years analyzed.
Aggregated at the state level, there is evidence of decreasing geographic variation in hysterectomy rates. Three pairs of US maps illustrate the changes between 2010 and 2013. (Note: calculations for age-adjusted utilization rates for each state are provided in Figure 3 and Supplemental Tables 2, 3 , and 4.) The green shade for inpatient hysterectomy lightens, indicating decreased utilization, while the blue shade for outpatient hysterectomy darkens, reflecting increased utilization.
For the overall rates, there is a lightening of the purple shade, reflecting lower rates of hysterectomy. The median decrease in hysterectomy utilization among states was e13.3% and the range was e25.8% to e6.7%. The boxplot (see Figure 4 ) illustrates a 12.3% drop in the median state-level hysterectomy rate (consistent with that reported in the Table) and a 48.5% decrease in the interquartile variance between 2010 and 2013 (0.0723 vs 0.0372, P ¼ .01).
The total annual payments for hysterectomy were analyzed over this time. Several factors are responsible for the 6.9% decrease in payments ($823 million to $771 million) between 2010 and 2013 (Table) . Lower total annual payments were related primarily to a 12.3% decrease in utilization and a shift from inpatient to outpatient surgery, for which the average case reimbursement is approximately 45% less. The effects of these factors were partially offset by increases in average inpatient (19.4%) and outpatient (19.8%) reimbursement. Change in age-adjusted utilization rates, Health Care Cost Institute, 2010e2013
Rates are per 10,000 woman-years. The effect of laparoscopy and outpatient surgery usage rates on total annual payments between 2010 and 2013 is illustrated in Figure 5 . For outpatient hysterectomy, there were increases in payments for laparoscopic and nonlaparoscopic approaches of $113 million (131%) and $26 million (28%), respectively. In contrast, for inpatient hysterectomy, there were decreases in payments for laparoscopic and nonlaparoscopic approaches of $16 million (14%) and $175 million (32%). The average total payment for all hysterectomies (inpatient and outpatient) rose 4.8% ($387), with the patient cost share increasing 11.9% ($84 per case) and the insurance payment increasing 4.2% ($303 per case).
Comment
In this analysis of more than 25 million commercially insured women, laparoscopy became the most common surgical approach for hysterectomy between 2010 and 2013. The proportion of hysterectomies performed laparoscopically increased 66.3%. The rapid growth in the use of laparoscopy builds upon years of steady, albeit slower increases in utilization. 2, 8, 9 The proportion of hysterectomies performed outpatient increased 67.8%, and outpatient hysterectomy became more common than inpatient in 2013. With the majority of hysterectomies now performed outpatient, epidemiological analyses of hysterectomy in the future will need to consider inpatient and outpatient procedures.
The increased use of laparoscopy has raised concerns about the finances of hysterectomy. 6 ACOG estimated that the addition of robotic-assisted laparoscopic hysterectomy could increase national health care spending by as much as $1.8 billion. We were unable to isolate the effect of robotic-assisted technology on payments, but the increased utilization of laparoscopy did not lead to an increase in overall payments. Two reasons to explain that the change in practice has not led to an increase in expenditures are a 12.5% decrease in utilization and a shift to outpatient surgery, for which reimbursement is 45% lower than a similar inpatient procedure.
These analyses also reveal how clinical practice is changing. Between 2010 and 2013, we observed fewer hysterectomies among reproductive-aged women and relatively stable rates among women >55 years. The most common indications for hysterectomy among reproductive-aged women (abnormal uterine bleeding, uterine fibroids, endometriosis, and chronic pelvic pain) decreased markedly. This may be due to the increased use of endometrial ablation and progesterone eluting intrauterine devices to control bothersome abnormal bleeding and chronic pelvic pain. These therapies have enabled many premenopausal women to control symptoms without resorting to invasive, extirpative surgery. 10 The number of hysterectomies for pelvic organ prolapse also decreased 19.4%. Rates of hysterectomy among Medicare beneficiaries diagnosed with prolapse decreased between 1999 and 2009, 11 the decade prior to the period we analyzed and before transvaginal mesh became so commonly used. The decrease we observed may be a continuation of this trend, but it may also be related to Federal Drug Administration safety advisories in 2008 and 2011 regarding the use of transvaginal mesh for prolapse procedures. 12 Cervical dysplasia, cervical cancer, endometrial hyperplasia, premalignant lesions of uncertain potential, cervical cancer, ovarian cancer, and a family history of cancer affect a much smaller number of women, and there was little change in the rates of utilization for those indications. The rate of hysterectomy for endometrial cancer increased 20%. The increase in endometrial cancer, which has an estrogen-dependent disease process, is likely related to rising rates of obesity, which exposes women to higher levels of endogenous estrogen.
13
There may be an opportunity to reduce the total annual payments for hysterectomy with improved adherence to clinical practice guidelines. Vaginal hysterectomy is the least morbid and expensive approach and, when appropriate, is preferred over a laparoscopic or abdominal approach by ACOG. However, during this time, the proportion of hysterectomies performed vaginally dropped 31.8% (from 15.1% to 11.5%). ajog.org
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The mean payment for vaginal hysterectomy ranges from $1310 to $2859 less (see Figure 4 ) than that for a laparoscopic or laparoscopic-assisted vaginal hysterectomy. While there is gynecological disease (eg, large fibroids or adhesive disease because of a previous surgery or endometriosis) that might complicate or even contraindicate a vaginal approach, systematic protocols can increase the proportion of vaginal hysterectomies. 14, 15 Programs promoting rational and safe utilization of vaginal hysterectomy could be a responsible strategy for further decreasing expenditures related to hysterectomy.
Geographic variation in hysterectomy utilization rates appears to be diminishing in this analysis, in contrast to earlier studies. Rates of hysterectomy utilization in the United States have traditionally been higher in the South and Midwest than those in the Northeast and West. 8, 16, 17 We found that the variation between regions of the country is decreasing significantly, by 48.5% between 2010 and 2013. This could be due to widespread dissemination of effective treatments that are an alternative to hysterectomy. Methodological reasons to explain the lower variation could be our use of age adjustment of utilization rates, which was not done in previous analyses, and the fact that women in our analysis had private insurance and were not representative of all payers.
There are other strengths and limitations to consider with this study. When comparing statewide utilization rates, it is important to note that we had to assume women with commercial insurance in the Health Care Cost Institute were similar to those with commercial insurance not in the Health Care Cost Institute and to those without commercial insurance (no insurance or covered by Medicare or Medicaid). The terms of our data use agreement with the Health Care Cost Institute also provide us access to claims for 2010 through 2013 with only 3 diagnostic codes. We are unable to obtain additional years of data or to receive additional diagnostic codes for claims. Fortunately, the limited number of diagnostic codes is unlikely to affect an analysis of inpatient and outpatient utilization.
Second, the payments for hysterectomy describe those of the procedure and the surgical admission but do not account for postoperative adverse events such as medical or surgical complications, readmission, or reoperation after discharge. These events could change our estimate of payments.
Third, we decided against including professional payments because they were missing from a large proportion (about one fourth) of hysterectomies. Fourth, we did not have confidence that we could comment on roboticassisted laparoscopy. The proportion of hysterectomies performed with robotic assistance, identified with ICD9 procedure codes 17.42 and 17.44, was lower than expected in 2010 and decreased markedly over time, a pattern strikingly different from other analyses. 2 Despite these limitations, an analysis of inpatient and outpatient claims data for 25 million to 26 million commercially insured women of all ages from 50 states provides important data regarding utilization and payments for hysterectomy.
Current hysterectomy practices are characterized by the more common use of laparoscopy and a shift toward outpatient surgery. Reproductive-aged women are undergoing fewer hysterectomies, probably because of the availability of less invasive methods of controlling menstrual disorders. Fewer hysterectomies and lower reimbursement rates for outpatient surgery are the most likely reasons for the decrease in the total annual payments. n Payments for hysterectomies, Health Care Cost Institute, 2010e2013
Nonlaparoscopic hysterectomies are the sum of payments for abdominal, laparoscopically assisted vaginal, and vaginal hysterectomies. The contribution of each surgical approach is calculated by multiplying the number of hysterectomies by its respective average annual payment. All costs are adjusted for inflation to 2013 US dollars, using the Medical Consumer Price Index.
LS, laparoscopic.
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